Mehrpouri et al. attempted to distinguish between patients with various lymphoproliferative disorders, including 91 CLL, 15 atypical CLL, 14 MCL, and 11 CD5-/CD10-lymphoma, using a panel of specific markers and flow cytometry [70]. This evidence concerns the gene MME and mantle cell lymphoma.